<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig3">
 <label>Fig. 3</label>
 <caption>
  <p>Second-line treatment of trial-ineligible and trial-eligible patients. Sequencing of treatments in 
   <bold>a</bold> trial-ineligible and 
   <bold>b</bold> potentially trial-eligible patients. Percentages in second-line treatment refer to all patients who had received the respective first-line treatment. The treatment group “CTx or other” includes chemotherapy as well as all other treatments, including combination therapies. Abbreviations: CTx, chemotherapy; IMiD, immunomodulatory drug; PI, proteasome inhibitor
  </p>
 </caption>
 <graphic xlink:href="277_2018_3449_Fig3_HTML" id="MO3" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
